Regardless of your thoughts on Uber, this does leave me a little confused given the good Governer's pro-business, small government stance. Isn't this government regulation? Isn't this the OPPOSITE of the political principles of the conservative Republican base? Shouldn't the marketplace be allowed to take care of the question?
They hit the point of know return.
It is unclear where in the diagnostic chain this idea fits. Is it someone that already carries a diagnosis of lymphoma, but there is a question the diagnosis is wrong? Is it using lab data to make a primary diagnosis (or suggestion of diagnoses) based on a clinic visit? Are they suggesting that this data fits an ancillary role in primary diagnosis in terms of resolving subtle discrepancies between diagnoses?
Pretty much all hematopoietic malignancy diagnoses do not come from the docs you see in the clinic. They come from the docs in the back rooms with microscopes, lasers, antibodies, sequencers, and computers. Is the user of this information the person in the front whom you talk to, or the person in the back making the actual diagnosis?
Szolovits is confident that that the teamâ(TM)s model can help doctors make more accurate lymphoma diagnoses based on more comprehensive evidence â" and could even be incorporated into future WHO guidelines.
To paraphrase Yet Another Famous Movie Quote: Getting something into the WHO guidelines ain't like dusting crops, boy.
I always thought extra charges for tethering were BS. When I got my first Google Nexus S phone on sprint, it was free, but they quickly shut down that capability.
I am on Ting (uses Sprint's network) now. Two phones (me and the wife) with as much phone/text/data as we need comes to around $70 TOTAL. I tether my tablet to my phone on the commute and all is well. My phone bill is one that I actually smile when I get after being used to getting ***raped by other carriers.
Oh yeah - and the customer service for Ting actually knows what they are talking about (for the little I have had to call them about) with short wait times and easy to understand reps. Not to sound like a Ting shill, but damn I love having an extra $100 per month...
It's hard to take seriously a source that says:
- The mechanism of action of vitamin D in infection... suggests pharmaceutical doses of vitamin D (1,000 IU per pound of body weight per day for several days) will effectively treat not only influenza and the common cold, but help treat a host of other seasonal infections, including meningitis, septicemia, and pneumonia, in both children and adults (emphasis added). source referenced in parent post
Personally, if I have septicemia or bacterial meningitis/pneumonia, I will take whatever the sensitivities say I should. If you choose to treat your N. meningitidis with Vit D, please stay at home so that you don't force everyone else to take prophylaxis.
Sib AC is correct. I have been using palemoon with tree style tabs for well over a year. No problems.
Palemoon overall has been a good experience. It is relatively stable (maybe a couple of crashes in a history of heavy heavy use) and speedy. It is worth checking out if you haven't already.
JavaFX is definitely an improvement over Swing. One other big improvement is its use of annotation based injection (@FXML annotation) to reduce lots of boiler-plate code to handle events from the UI and such.
As to IDE support, Oracle's SceneBuilder is OK - not the best but it can be helpful in getting layouts set up.
I really hate Swing but find JavaFX very nice to work in.
Hmmm...we covered Ehler-Danlos and collagen synthesis disorders the first year of med school (might have even been in the first couple of months).
Glad to hear you finally got a diagnosis.
someone who works 12 hours days for 3 months is a monkey. really. that's about all I have to say about that.
Only 72 hours in a week??? And only for 3 months? I call that a vacation!
So how would you do an RCT for something like Ebola, a disease that really only manifests itself when it starts to spread? Would you ask for volunteers to be infected outside of an outbreak in ordered to test efficacy/safety? Is there an IRB board in the country that would authorize something like this?
I actually do agree that you don't want to get all Mavericky with drug experimentation. At a certain point though you need patients with the disease to test efficacy and safety. If the only time you have patients is during an outbreak then when else can you test in vivo responses?
Except printers put in identifying information into their printed pages.
Although AFAIK crayons and/or markers are not identifiable...
It was panglossian for him to think this would all turn out for the best.
You could be a carrier for months to years and be a vector without showing up positive in a test.
Just for the record, this is not correct. While it is true that there is an eclipse period during which testing is not useful (as indeed, there is an eclipse period for any viral infection), for HIV that window is currently very small.
- Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance dataâ"United States and 6 dependent areasâ"2011. HIV Surveillance Supplemental Report 2013;18(No. 5). http://www.cdc.gov/hiv/library/reports/ surveillance/. Published October 2013.
- Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. Available at http://stacks.cdc.gov/view/cdc/23447. Published June 27, 2014..
In fact, too much data has been shown to lead to more misdiagnoses in ER's.
What type of data are you talking about? Lots of largely irrelevant lab data? (oh look...an elevated ESR!) Or is it historical data (Why yes Doctor, I do have a metal plate in my head. Is that bad for an MRI?)
The clinical history is one of the most powerful diagnostic tools available. Even in the ED.